Drug intelligence / Profile preview

Densy

Development stage: Unknown
Lead developer: Jointcare Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

**Densy** is an oral branded calcium and vitamin-mineral dietary supplement marketed by Jointcare Pharmaceuticals for bone-health support and management or prevention of low calcium intake or calcium deficiency. Public product listings describe a tablet containing calcium citrate, magnesium, and cholecalciferol, with reported strengths of calcium citrate 1,000 mg, magnesium 22.5 mg, and vitamin D3 250 IU. Cholecalciferol is converted in the body to active vitamin D metabolites that activate the vitamin D receptor, increasing intestinal calcium absorption; calcium and magnesium provide nutritional support for bone mineralization and normal neuromuscular function.

Brand names: Densy

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Densy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Densy.

Explore the full profile